Inflammation and lipid signaling in the etiology of insulin resistance - PubMed
- ️Sun Jan 01 2012
Review
Inflammation and lipid signaling in the etiology of insulin resistance
Christopher K Glass et al. Cell Metab. 2012.
Abstract
Inflammation and lipid signaling are intertwined modulators of homeostasis and immunity. In addition to the extensively studied eicosanoids and inositol phospholipids, emerging studies indicate that many other lipid species act to positively and negatively regulate inflammatory responses. Conversely, inflammatory signaling can significantly alter lipid metabolism in the liver, adipose tissue, skeletal muscle, and macrophage in the context of infection, diabetes, and atherosclerosis. Here, we review recent findings related to this interconnected network from the perspective of immunity and metabolic disease.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures

Saturated fatty acids (SFAs) stimulate inflammatory pathways through Tlr4 dependent and independent mechanisms. SFAs are also precursors for ceramide biosynthesis, and inflammatory pathway stimulation by SFAs, as well as cytokines, induces the enzymes which produce ceramide, providing two mechanisms for increased ceramide content. Omega 3 FAs produce anti-inflammatory effects by stimulating GPR120 and production of resolvins and protectins. Omega 6 FAs can be proinflammatory through their metabolism to leukotrienes and prostaglandins.

(A) Tlr4 and TNF receptor signaling stimulates the TAK1/TAB1 complex which then activates IKKβ and MKK4 to stimulate the downstream NFκB and JNK1 inflammatory pathways. (B) Omega 3 FAs activate GPR120 causing it to associate with β arrestin-2. The GPR120•β arrestin-2 complex then undergoes endocytosis and the internalized β arrestin-2 binds to TAB1, “stealing” it from the TAK1 complex, causing TAK1 inactivation with inhibition of subsequent downstream proinflammatory signaling. Adapted from (Oh et al., 2010).

Impact of inflammation on lipid metabolism. Inducers and amplifiers of inflammation include ligands for pattern recognition receptors (e.g. LPS), cytokines (e.g., Il1β) and saturated fatty acids (SFAs). Each of these inflammatory stimuli influence lipid metabolism in liver, skeletal muscle and adipose tissue by acting on both parenchymal cells and resident immune cells. Although some effects are seen in all three organs (e.g., increased TG hydrolysis), other effects may be organ-specific (e.g., increased fatty acid biosynthesis in liver).
Similar articles
-
Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Bastard JP, et al. Eur Cytokine Netw. 2006 Mar;17(1):4-12. Eur Cytokine Netw. 2006. PMID: 16613757 Review.
-
Age-related inflammation and insulin resistance: a review of their intricate interdependency.
Park MH, Kim DH, Lee EK, Kim ND, Im DS, Lee J, Yu BP, Chung HY. Park MH, et al. Arch Pharm Res. 2014 Dec;37(12):1507-14. doi: 10.1007/s12272-014-0474-6. Epub 2014 Sep 20. Arch Pharm Res. 2014. PMID: 25239110 Free PMC article. Review.
-
NOD1 activators link innate immunity to insulin resistance.
Schertzer JD, Tamrakar AK, Magalhães JG, Pereira S, Bilan PJ, Fullerton MD, Liu Z, Steinberg GR, Giacca A, Philpott DJ, Klip A. Schertzer JD, et al. Diabetes. 2011 Sep;60(9):2206-15. doi: 10.2337/db11-0004. Epub 2011 Jun 29. Diabetes. 2011. PMID: 21715553 Free PMC article.
-
Ceramides in insulin resistance and lipotoxicity.
Summers SA. Summers SA. Prog Lipid Res. 2006 Jan;45(1):42-72. doi: 10.1016/j.plipres.2005.11.002. Epub 2005 Dec 19. Prog Lipid Res. 2006. PMID: 16445986 Review.
-
Shirif AZ, Kovačević S, Brkljačić J, Teofilović A, Elaković I, Djordjevic A, Matić G. Shirif AZ, et al. Int J Mol Sci. 2021 Jul 4;22(13):7206. doi: 10.3390/ijms22137206. Int J Mol Sci. 2021. PMID: 34281257 Free PMC article.
Cited by
-
Ertunc ME, Hotamisligil GS. Ertunc ME, et al. J Lipid Res. 2016 Dec;57(12):2099-2114. doi: 10.1194/jlr.R066514. Epub 2016 Jun 21. J Lipid Res. 2016. PMID: 27330055 Free PMC article. Review.
-
Kheder RK, Hobkirk J, Stover CM. Kheder RK, et al. Front Cell Dev Biol. 2016 Jun 22;4:61. doi: 10.3389/fcell.2016.00061. eCollection 2016. Front Cell Dev Biol. 2016. PMID: 27446914 Free PMC article.
-
Eicosanoids in metabolic syndrome.
Hardwick JP, Eckman K, Lee YK, Abdelmegeed MA, Esterle A, Chilian WM, Chiang JY, Song BJ. Hardwick JP, et al. Adv Pharmacol. 2013;66:157-266. doi: 10.1016/B978-0-12-404717-4.00005-6. Adv Pharmacol. 2013. PMID: 23433458 Free PMC article. Review.
-
The role of hepatokines in metabolism.
Stefan N, Häring HU. Stefan N, et al. Nat Rev Endocrinol. 2013 Mar;9(3):144-52. doi: 10.1038/nrendo.2012.258. Epub 2013 Jan 22. Nat Rev Endocrinol. 2013. PMID: 23337953 Review.
-
Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans.
Nowotny B, Zahiragic L, Krog D, Nowotny PJ, Herder C, Carstensen M, Yoshimura T, Szendroedi J, Phielix E, Schadewaldt P, Schloot NC, Shulman GI, Roden M. Nowotny B, et al. Diabetes. 2013 Jul;62(7):2240-8. doi: 10.2337/db12-1179. Epub 2013 Mar 1. Diabetes. 2013. PMID: 23454694 Free PMC article. Clinical Trial.
References
-
- Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B, Ferrieres J. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr. 2008;87:1219–1223. - PubMed
-
- Barish GD, Downes M, Alaynick WA, Yu RT, Ocampo CB, Bookout AL, Mangelsdorf DJ, Evans RM. A Nuclear Receptor Atlas: macrophage activation. Molecular endocrinology. 2005;19:2466–2477. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources